Works matching IS 26882663 AND DT 2022 AND VI 3 AND IP 2

Results: 20

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.143

By:

Zhou, Zhongcheng;
Du, Peng;
Li, Ning;
Xiong, Xinxin;
Tang, Shengjun;
Dai, Qinjin;
Wang, Taorui;
Yu, Meixing;
Man, Miao;
Lam, Kelvin;
Baptista‐Hon, Daniel T.;
Tai, Wa Hou;
Monteiro, Olivia;
Ng, Weng Sam;
Lee, Un Man;
Liu, Zhihai;
Zhang, Kang;
Li, Gen

Publication type:

Article

Erratum.

Published in:: 2022
Publication type:: Correction Notice

Role of chemokine systems in cancer and inflammatory diseases.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.147

By:

Li, Hongyi;
Wu, Min;
Zhao, Xia

Publication type:

Article

Pathogenesis and treatment of multiple myeloma.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.146

By:

Yang, Peipei;
Qu, Ying;
Wang, Mengyao;
Chu, Bingyang;
Chen, Wen;
Zheng, Yuhuan;
Niu, Ting;
Qian, Zhiyong

Publication type:

Article

Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.144

By:

Huang, Zhao;
Zhang, Zhe;
Zhou, Chengwei;
Liu, Lin;
Huang, Canhua

Publication type:

Article

LncRNAs and CircRNAs in cancer.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.141

By:

Yin, Xin;
Lin, Huiran;
Lin, Lei;
Miao, Lei;
He, Jing;
Zhuo, Zhenjian

Publication type:

Article

Programmed death‐ligand 1 expression on CD22‐specific chimeric antigen receptor‐modified T cells weakens antitumor potential.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.140

By:

Liu, Jie;
Zhang, Fengjuan;
Yu, Jian;
Zhao, Qi

Publication type:

Article

TRPV1, a novel biomarker associated with lung cancer via excluding immune infiltration.

Published in:

2022

By:

Gao, Rui;
Meng, Mei;
Zhou, Xianchao;
Yu, Miao;
Li, Zhifan;
Li, Jingquan;
Wang, Xiaonan;
Song, Yizhi;
Wang, Hui;
He, Jian

Publication type:

Letter to the Editor

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.138

By:

Xi, Jinxiang;
Si, Xiuhua April

Publication type:

Article

Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.137

By:

Jiang, Zhongyi;
Zhu, Haitao;
Wang, Pusen;
Que, Weitao;
Zhong, Lin;
Li, Xiao‐Kang;
Du, Futian

Publication type:

Article

Erratum.

Published in:: 2022
Publication type:: Correction Notice

Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.132

By:

Dai, Ji‐Min;
Zhang, Xue‐Qin;
Zhang, Jia‐Jia;
Yang, Wei‐Jie;
Yang, Xiang‐Min;
Bian, Huijie;
Chen, Zhi‐Nan

Publication type:

Article

Deletion of Trp53 and Rb1 in Ctsk‐expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.131

By:

Li, Yang;
Yang, Shuting;
Liu, Yang;
Yang, Shuying

Publication type:

Article

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.130

By:

Li, Qianqian;
Zhang, Mengyi;
Liang, Ziteng;
Zhang, Li;
Wu, Xi;
Yang, Chaoying;
An, Yimeng;
Tong, Jincheng;
Liu, Shuo;
Li, Tao;
Cui, Qianqian;
Nie, Jianhui;
Wu, Jiajing;
Huang, Weijin;
Wang, Youchun

Publication type:

Article

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.129

By:

Yang, Hao;
Liu, Penghui;
Zhang, Yong;
Du, Tingfu;
Zhou, Yanan;
Lu, Shuaiyao;
Peng, Xiaozhong

Publication type:

Article

Redox signaling at the crossroads of human health and disease.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.127

By:

Zuo, Jing;
Zhang, Zhe;
Luo, Maochao;
Zhou, Li;
Nice, Edouard C.;
Zhang, Wei;
Wang, Chuang;
Huang, Canhua

Publication type:

Article

Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.125

By:

Li, Jiao;
Zhou, Jian‐Kang;
Mu, Xiaoyu;
Shen, Shu;
Xu, Xiaomin;
Luo, Yao;
Luo, Yuxin;
Ming, Yue;
Wu, Yuangang;
Peng, Yong

Publication type:

Article

STAT3 pathway in cancers: Past, present, and future.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.124

By:

Wang, Han‐Qi;
Man, Qi‐Wen;
Huo, Fang‐Yi;
Gao, Xin;
Lin, Hao;
Li, Su‐Ran;
Wang, Jing;
Su, Fu‐Chuan;
Cai, Lulu;
Shi, Yi;
Liu, Bing;
Bu, Lin‐Lin

Publication type:

Article

SENP3‐mediated TIP60 deSUMOylation is required for DNA‐PKcs activity and DNA damage repair.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.123

By:

Han, Yang;
Huang, Xin;
Cao, Xiaoyu;
Li, Yuchen;
Gao, Lei;
Jia, Jin;
Li, Gang;
Guo, Hejiang;
Liu, Xiaochang;
Zhao, Hongling;
Guan, Hua;
Zhou, Pingkun;
Gao, Shanshan

Publication type:

Article

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice.

Published in:

MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.117

By:

Fang, Enyue;
Liu, Xinyu;
Liu, Xiaohui;
Li, Ming;
Wang, Ling;
Li, Miao;
Zhang, Zelun;
Li, Yuhua;
Yu, Yongxin

Publication type:

Article